(188)Re-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside

Hepatocellular carcinoma (HCC) is the 5th most common tumour worldwide and has a dark prognosis. For nonoperable cases, metabolic radiotherapy with Lipiodol labelled with β-emitters is a promising therapeutic option. The Comprehensive Cancer Centre Eugène Marquis and the National Graduate School of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lepareur, Nicolas, Ardisson, Valérie, Noiret, Nicolas, Garin, Etienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299367/
https://www.ncbi.nlm.nih.gov/pubmed/22518301
http://dx.doi.org/10.1155/2012/278306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299367/
https://www.ncbi.nlm.nih.gov/pubmed/22518301
http://dx.doi.org/10.1155/2012/278306

Ejemplares similares